tiprankstipranks
Trending News
More News >
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market

MiNK Therapeutics (INKT) Income Statement

Compare
143 Followers

MiNK Therapeutics Income Statement

Last quarter (Q4 2024), MiNK Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, MiNK Therapeutics's net income was $-2.46M. See MiNK Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 2.70B$ 0.00$ 0.00
Gross Profit
$ 0.00$ -204.62K$ -28.24B$ -28.36B$ -55.06K
Operating Expenses
$ 10.65B$ 22.92M$ 30.95M$ 18.61M$ 10.80M
Depreciation and Amortization
$ 0.00$ 204.62K$ 121.75K$ 77.96K$ 55.06K
EBITDA
$ 0.00$ -22.25M$ -30.83M$ -27.70M$ -13.74M
Operating Income
$ 0.00$ -22.92M$ -30.95M$ -28.36M$ -14.64M
Other Income/Expenses
$ 0.00$ 463.25K$ 2.96M$ -1.85M$ -1.60M
Pretax Income
$ -10.78B$ -22.46M$ -27.99M$ -30.21M$ -16.24M
Net Income
$ -10.78B$ -22.46M$ -24.78M$ -23.11M$ -15.68M
Per Share Metrics
Basic EPS
$ -285.82$ -0.65$ -0.74$ -0.69$ -0.47
Diluted EPS
$ -285.82$ -0.65$ -0.74$ -0.69$ -0.47
Weighted Average Shares Outstanding
37.73M 34.36M 33.67M 33.48M 33.09M
Weighted Average Shares Outstanding (Diluted)
37.73M 34.36M 33.67M 33.48M 33.09M
Currency in USD

MiNK Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis